Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer

Research output: Contribution to journalArticle

Original languageEnglish
JournalClinical Lung Cancer
DOIs
Publication statusAccepted/In press - Mar 3 2016

Keywords

  • Activity of nivolumab
  • Anti-PDL1
  • ERBB family
  • Immunotherapy
  • Lung adenocarcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this